Navigation Links
Some NHS trusts consistently outperform others on patient experience
Date:3/14/2012

Some NHS trusts consistently outperform others on a range of measures of patient experience, finds research published online in BMJ Quality & Safety.

Furthermore, the top performers tend to be Foundation Trusts and teaching hospitals, the study shows.

Patient experience is one of the five domains for assessing NHS performance (NHS Outcomes Framework) and is recognised internationally as a key dimension of healthcare quality.

But it is one of the more difficult areas to measure because of the many contributory factors involved, say the authors.

The authors, from health think-tank The King's Fund, and the Picker Institute Europe, used data from inpatient, outpatient and emergency care surveys from 145 hospital trusts in England for 2008 and 2009.

They looked at six areas (domains), which were common to the various surveys, to reflect patient experience. These were: cleanliness; dignity and respect; consistency of communication; patient involvement in decisions; information provision; and confidence in staff.

They then applied a series of statistical techniques to examine whether or not trust performance was consistent across the different surveys, and to identify factors associated with performance, such as foundation trust status and deprivation levels among the trust's patients.

Their analysis showed that, overall, trusts scored an average of 70 or higher out of 100 across all the surveys for patient experience, with the exception of information provision on issues such as drug side effects and danger signals to look out for after discharge.

Domains with the largest number of above average scoring trusts were dignity and respect (85 trusts) and consistency of communication (80 trusts). Domains with the smallest number of above average performers were confidence in staff (43 trusts) and patient involvement in decisions (50).

Domains with highest number of below average performers were information provision (52 trusts) and confidence in staff (40 trusts); those with the smallest number of below average performers were cleanliness (17 trusts) and involvement in decisions (8 trusts).

But the analysis identified certain trusts which performed consistently above or below average on all six domains in all three surveys.

One in five (21%) trusts performed above average in all the surveys. Most had Foundation Trust status, but not one was in London.

At the other end of the scale, six trusts (4%) performed below average in all the surveys. All these trusts were in London, and none had Foundation Trust or teaching hospital status.

Below average performers also had the highest average deprivation scores and the lowest proportion of patients from white backgrounds.

Feedback from patients from black and minority ethnic backgrounds shows that they are often less satisfied with the healthcare they receive than their white peers, which may have to do with language and cultural factors, say the authors.

But they say: "Population differences should never be seen as an 'excuse' or 'justification' for poor patient experience."

They suggest that the consistency of their findings indicate system wide successes or failures, and that some trusts are more successful than others at fostering a culture or mechanisms for delivering a good experience for their patients.

While the performance of trusts, overall, was skewed towards higher scores, the authors point out: "However, the survey results overall show considerable room for improvement."


'/>"/>

Contact: Stephanie Burns
sburns@bmjgroup.com
44-207-383-6920
BMJ-British Medical Journal
Source:Eurekalert

Related medicine news :

1. Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement
2. Black Box Drug Warning Labels Applied Inconsistently: Study
3. Male batterers consistently overestimate rates of violence toward partners
4. New Blood Thinner May Outperform Warfarin for Irregular Heartbeat
5. Research finds surgery outperforms drug therapy in treatment of benign prostatic hyperplasia
6. Compression Device May Outperform Meds After Hip Surgery
7. Hormone Outperforms Insulin in Diabetic Mice
8. From Refrigerator Mothers to untangling the genetic roots of autism
9. Its not solitaire: Brain activity differs when one plays against others
10. Women born to older mothers have a higher risk of developing breast cancer
11. Nurturing mothers rear physically healthier adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Diego, CA (PRWEB) , ... December 05, 2016 , ... ... seen and heard the dangers and downsides of patients who do not do their ... The field of cosmetic dermatology is in the midst of a renaissance and every ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Israel , December 5, 2016 ... identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase ... BL-8040, the Company,s leading oncology platform at the ongoing 58th ... San Diego, California . ... , , ...
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) ... tolerability profile of ropeginterferon alfa-2b versus HU ... long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization in ... this data to the FDA as it seeks approval for ...
(Date:12/4/2016)... HOUSTON , Dec. 3, 2016   Pairnomix, LLC, ... Precision Medicine Alliance (PEPMA) recognized by the White House, today ... individualized approach to the identification of candidate therapies for a ... SCN8A gene were presented at the 70 th ... in Houston, TX , December 2-6, 2016.  ...
Breaking Medicine Technology: